Clinical trials
Completed Phase 3 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| Eli Lilly and Company | 2 |
| GE Healthcare | 2 |
| Janssen Pharmaceutical K.K. | 2 |
| Materia Medica Holding | 2 |
| Novartis | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| VA Office of Research and Development | 2 |
| Alzheimer's Prevention and Reversal Project, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 52 |
| Alzheimer Disease | 22 |
| Dementia | 13 |
| Memory Disorders | 7 |
| Mental Disorders | 5 |
| Nervous System Diseases | 5 |
| Brain Injuries, Traumatic | 4 |
| Central Nervous System Diseases | 3 |
| Delirium | 3 |
| Neurodegenerative Diseases | 3 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.